Diasorin is the global leader in Molecular Diagnostics and Immunodiagnostics market. Discover all Diasorin’s diagnostic solutions.
The technologies of immunodiagnostics and molecular diagnostics applied to the tests of Diasorin are based on automated technological platforms developed by partner companies based on specifications indicated by Diasorin.
For over 50 years, Diasorin has been providing diagnostic solutions to the clinical world, healthcare and life science companies, and academic research.
About us About us Diasorin S.p.A. is an Italian biotechnology company based in Saluggia. The company’s business is centered on in vitro diagnostics. The origins of the company go back to 1968 when, at the initiative of Fiat and Montecatini, Sorin Biomedica was founded from the Società Ricerche Impianti Nucleari - Sorin.
Diasorin: The Diagnostic Specialist Diasorin elevates your diagnostic stewardship initiatives with comprehensive molecular & immunodiagnostic solutions for infectious disease testing.
Find the latest DiaSorin S.p.A. (DIA.MI) stock quote, history, news and other vital information to help you with your stock trading and investing.
Headquartered in Italy and listed on the Italian Stock Exchange within the FTSE MIB Index, Diasorin is a global leader in the In Vitro Diagnostic (IVD) field and, since 2021, has been active in...
Diasorin is one of the world leaders in the Laboratory Diagnostics and Healthcare market. Visit the website for more information.
Diasorin provides a broad range of specialized diagnostic solutions in the immunodiagnostics market, including systems, techniques and testing tools.
DiaSorin S.p.A. (IT:DIA) has released an update. DiaSorin S.p.A. reported a strong performance for the first nine months of 2024, with revenues reaching €876 million, a 4% increase at constant ...